Delivery Order SPE2DE21D0029-SPE2D626F8542
- Not listed
- Becton, Dickinson and Company (BD), through its Infectious Diseases Systems (IDS) division, received a delivery order valued at $1,786.65 from the Department of Defense's Medical Supply Chain on July 31, 2025. The contract is a fixed price agreement with economic price adjustment provisions and carries no set-aside designation, reflecting BD's competitive standing as a large medical technology manufacturer. Performance will be completed by August 21, 2025, at BD's facility in Sparks Glencoe,...
- Becton, Dickinson and Company's Diagnostic Systems (IDS) division has been awarded a delivery order valued at $1,786.65 by the Department of Defense's Medical Supply Chain division for performance in Sparks Glencoe, Maryland. This fixed-price delivery order with economic price adjustment provisions was awarded on July 22, 2025, with an ultimate completion date of August 12, 2025. The contract utilizes no small business set-aside designation, reflecting BD's competitive position as a large,...
- The U.S. Department of Defense Medical Supply Chain awarded a $3,573.30 fixed-price delivery order to Becton, Dickinson and Company (BD), Infectious Disease Systems division, on September 5, 2025, with an ultimate completion date of September 26, 2025. This delivery order was issued without a set-aside designation and represents a task order under BD's existing federal contract vehicles. The work will be performed at BD's facility in Sparks Glencoe, Maryland. BD, a global medical technology...
- Becton, Dickinson and Company (BD) was awarded a delivery order valued at $225,791.91 on September 24, 2025, for other medical supplies and equipment. The contract is a firm fixed-price delivery order with no small business set-aside designation, with an ultimate completion date of October 29, 2026. Performance will take place at BD's facility in Franklin Lakes, New Jersey. The contract is funded by the Medical Supply Chain, a defense-focused federal agency, reflecting BD's ongoing role as a...
- Becton, Dickinson and Company (BD), through its Diagnostic Systems division, was awarded a delivery order valued at $3,402.60 by the Department of Defense's Medical Supply Chain on July 17, 2025, for the Kit Affirm VPIII Clinical. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of August 7, 2025, and will be performed in Sparks Glencoe, Maryland. The award was made on a full and open competition basis without set-aside designation, consistent...
- This federal contract award, valued at $199,703.26, was issued by the Department of Veterans Affairs (VA) to Becton, Dickinson and Company (BD), a leading manufacturer of medical devices, instruments, and diagnostic products. The contract is for "BACTERIAL IDENTIFICATION AND SUSCEPTIBILITY TESTING" services and has an ultimate completion date of March 31, 2026. BD's IDS division, operating as BD Diagnostic Systems, is the prime contractor for this delivery order contract. The...
- Becton, Dickinson and Co (BD) was awarded a $437,837.49 firm fixed-price delivery order on September 24, 2025, by the Defense Health Agency's Medical Supply Chain division for medical supplies and equipment. The contract, which carries no small business set-aside designation, has an ultimate completion date of October 28, 2026, and will be performed at BD's facility in Franklin Lakes, New Jersey. As a leading global medical technology manufacturer, BD will deliver specialized medical devices and...
- Becton, Dickinson and Company's Infectious Diseases Systems division received a delivery order valued at $1,361.04 for the KIT AFFIRM VPIII CLINICAL from the Defense Health Agency's Medical Supply Chain division. Awarded on September 8, 2025, with an ultimate completion date of September 29, 2025, this fixed-price delivery order with economic price adjustment carries no set-aside designation. The work will be performed in Sparks Glencoe, Maryland. This delivery order represents a task order...
- Becton, Dickinson and Company (BD), through its Diagnostic Systems (IDS) division, was awarded a delivery order valued at $104.3K by the Defense Health Agency for microbiology identification cards and antimicrobial susceptibility testing analyzer equipment along with associated reagents and consumables. The award, issued on October 1, 2025, carries a firm fixed price structure with an ultimate completion date of September 30, 2030, and will be performed in Sparks Glencoe, Maryland. This delivery...
- This is a $19,956.48 firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases to Becton, Dickinson and Company (BD) through a total small business set-aside. The contract is for the provision of medical supplies, devices, laboratory equipment, and diagnostic products by BD's IDS division, operating as BD Diagnostic Systems, to support government healthcare and biomedical...
- SPE2DE21D0029Indefinite Delivery Contract
- SPE2DE21D0029-SPE2D626F8542Delivery Order
Becton, Dickinson and Company's Infectious Disease Systems (IDS) division received a delivery order award valued at $2,079.30 from the Medical Supply Chain, a defense-oriented federal agency, with an ultimate completion date of November 10, 2025. The award, issued on November 3, 2025, represents a fixed-price contract with economic price adjustment provisions and carries no small business set-aside designation. The work will be performed at BD's facility in Sparks Glencoe, Maryland. This delivery order is a child contract, indicating it likely derives from a larger indefinite delivery vehicle (IDV) or blanket purchase agreement under which BD maintains standing authorization to supply diagnostic products and services to federal healthcare agencies. BD maintains an extensive portfolio of federal contracts exceeding $500 million in prime awards, positioning the company as a critical supplier of advanced diagnostic laboratory equipment and in vitro diagnostic solutions to the Department of Veterans Affairs, Defense Health Agency, National Institutes of Health, and other federal healthcare entities. The company's IDS division specializes in blood culture systems, microbiology analyzers, molecular testing capabilities, and diagnostic reagents that support clinical operations across federal medical facilities. BD's established position as a primary federal supplier is reinforced through multiple large IDVs, including a $30 million Department of Veterans Affairs Federal Supply Schedule contract and a $7 million Defense Health Agency blanket purchase agreement for diagnostic testing equipment and supplies, from which this delivery order was likely issued.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 11/3/25 |